PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 4 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
2'-hydroxy-4,4',6'-trimethoxychalcone showed the most potent cytotoxic activity against human promyelocytic leukemia (HL-60) and human breast cancer (MCF-7) cell lines [PMID:25057485].
Rhizome extracts were used to synthesize silver nanoparticles to evaluate antimicrobial activity against multidrug-resistant urinary tract infecting (MDR-UTI) pathogens [PMID:36074190].
Evidence summary
PubMed sources
- 1.PMID: 25057485 (2014) — Phytochemicals from Kaempferia angustifolia Rosc. and their cytotoxic and antimicrobial activities. · BioMed research international
- 2.PMID: 21475124 (2011) — A new abietene diterpene and other constituents from Kaempferia angustifolia Rosc. · Molecules (Basel, Switzerland)
- 3.PMID: 36074190 (2022) — Phytogenic silver nanoparticles from tissue-cultured Kaempferia angustifolia - an underutilized medicinal herb: a comparative antibacterial study on urinary pathogens. · Journal, genetic engineering & biotechnology
- 4.PMID: 34694165 (2022) — Phytochemicals of Zingiberaceae family exhibit potentiality against SARS-CoV-2 main protease identified by a rational computer-aided drug design. · Natural product research